GFAP and peripheral neuropathy: In this study, we set out to determine the usability of serum NfL (sNfL), GFAP (sGFAP), and RNFL as reliable and easily accessible biomarkers of the progression and severity of chronic oxaliplatin-induced peripheral neuropathy (OIPN).